Cytotoxic T Lymphocytes (ctls) - Infectious Diseases

Relevant Publications

Light-Activated In Situ Vaccine with Enhanced Cytotoxic T Lymphocyte Infiltration and Function for Potent Cancer Immunotherapy.

Issue Release: 2024

Cancer stem cell-derived exosomes in CD8 T cell exhaustion.

Issue Release: 2024

A dual-enzyme-like photosensitive nanozyme for remodeling the tumor immunosuppressive microenvironment to enhance immunotherapy.

Issue Release: 2024

Biosynthetic MnSe Nanobomb with Low Mn Content Activates the cGAS-STING Pathway and Induces Immunogenic Cell Death to Enhance Antitumour Immunity.

Issue Release: 2024

HTLV-1 vaccination Landscape: Current developments and challenges.

Issue Release: 2024

The pathogenic response of cytotoxic T‑lymphocytes, a common therapeutic target for cancer, has a direct impact on treatment outcomes (Review).

Issue Release: 2024

Enzyme-Instructed Photoactivatable Supramolecular Antigens on Cancer Cell Membranes for Precision-Controlled T-Cell-Based Cancer Immunotherapy.

Issue Release: 2024

Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer.

Issue Release: 2024

Triune Nanomodulator Enables Exhausted Cytotoxic T Lymphocyte Rejuvenation for Cancer Epigenetic Immunotherapy.

Issue Release: 2024

IL-3-driven T cell-basophil crosstalk enhances antitumor immunity.

Issue Release: 2024

USP47 deficiency in mice modulates tumor infiltrating immune cells and enhances antitumor immune responses in prostate cancer.

Issue Release: 2024

Reassessing granzyme B: unveiling perforin-independent versatility in immune responses and therapeutic potentials.

Issue Release: 2024

Nucleolar protein TAAP1/ confers pro-survival signaling in non-small cell lung cancer.

Issue Release: 2024

Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors.

Issue Release: 2024

Hybrid Ginseng-derived Extracellular Vesicles-Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis.

Issue Release: 2024

Cell softness renders cytotoxic T lymphocytes and T leukemic cells resistant to perforin-mediated killing.

Issue Release: 2024

Single cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity.

Issue Release: 2024

Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy.

Issue Release: 2024

Unfolding the Complexity of Exosome-Cellular Interactions on Tumour Immunity and Their Clinical Prospects in Nasopharyngeal Carcinoma.

Issue Release: 2024

Single-cell transcriptomic and T cell antigen receptor analysis of human cytomegalovirus (hCMV)-specific memory T cells reveals effectors and pre-effectors of CD8 - and CD4 -cytotoxic T cells.

Issue Release: 2024

What is a Cohort in Infectious Diseases?

What are the Implications of Colonization in Healthcare Settings?

What Infections Can Be Diagnosed Using Throat Swabs?

How Can Zoonotic Diseases be Prevented?

What are the Guidelines for Ventilation in Healthcare Settings?

What is Clostridium Botulinum?

What is Flaviviridae?

What are the Global Health Implications?

What Are the Outcomes of Host-Pathogen Interactions?

How Does Aspirin Work?

Partnered Content Networks

Relevant Topics